The study objective was to evaluate the association of proton pump inhibitors (PPIs) and community-acquired pneumonia (CAP). The design was a meta-analysis of nine case–controlled and cohort ...

Proton pump inhibitors (PPIs) are a class of very effective and generally safe medicines used to treat heartburn, gastroesophageal reflux disease (GERD), and gastric ulcers.But not everyone who ...

Background Medical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon ...

Edmund Pezalla, MD, MPH, spoke with Physician’s Weekly about findings that show proton pump inhibitors may not increase risk ...

Proton pump inhibitors (PPIs) are a class of medications used to treat conditions involving excess stomach acid, such as gastroesophageal reflux disorder (GERD) and stomach ulcers. They work by ...

Studying the impact of proton pump inhibitors, or PPIs, scientists found that people who take these drugs for four-and-a-half years, or more, were 33 per cent more likely to develop the ...

Eosinophilic esophagitis (EoE) is a multifaceted disease marked by diverse clinical features, including variations in age of ...

A recent expert group consensus has endorsed the use of vonoprazan for managing refractory gastroesophageal reflux disease ...